Otsuka Pharmaceutical, Senju deal

Otsuka granted Senju co-promotion rights in Japan for carteolol/latanoprost ( OPC-1085EL). Last year, Otsuka submitted an NDA in Japan for OPC-1085EL to treat glaucoma and ocular hypertension. The fix...